This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $100.90 in the latest trading session, marking a +0.11% move from the prior day.
CVS Health (CVS) Scales a 52-Week High: What's Driving It?
by Zacks Equity Research
Robust performance by the Pharmacy Services and Health Care Benefits arms is driving the top line for CVS Health (CVS).
CVS Health (CVS) Outlines Growth Strategy, Initiates 2022 View
by Zacks Equity Research
CVS Health's (CVS) new strategy capitalizes on the considerable opportunity to make health care more convenient, personalized and affordable for consumers.
The Zacks Analyst Blog Highlights: UNH, PG, CVS, SQ, and ABB
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UNH, PG, CVS, SQ, and ABB.
Top Analyst Reports for UnitedHealth, Procter & Gamble & CVS
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), The Procter & Gamble Company (PG), and CVS Health Corporation (CVS).
CVS Health (CVS) New Alliance to Boost Digital Transformation
by Zacks Equity Research
CVS Health's (CVS) collaboration with Microsoft will accelerate digital transformation and empower employees to provide more customized and affordable care.
Microsoft (MSFT) to Support CVS Health's Digital Transformation
by Zacks Equity Research
Microsoft (MSFT) will be teaming up with CVS Health to advance work on developing innovative solutions to boost customer health outcomes.
Here's Why You Should Retain CVS Health (CVS) Stock for Now
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS) on strong third-quarter 2021 results and raised full-year outlook.
CVS Health (CVS) Down 4.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Stock Reports for Coca-Cola, Shopify & Advanced Micro Devices
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including The Coca-Cola Company (KO), Shopify Inc. (SHOP), and Advanced Micro Devices, Inc. (AMD).
CVS Health (CVS) Installs Time-Delay Safes in Texas Pharmacies
by Zacks Equity Research
CVS Health's (CVS) time-delay safes reduce theft and diversion of opioid medications and boost the security of stores, creating a safe environment for patients and staff.
CVS Health's (CVS) New Measures to Boost Omnichannel Health
by Zacks Equity Research
CVS Health's (CVS) new measures will support its strategy of making health care more affordable, accessible and convenient for consumers.
Best Growth Stocks to Buy for November 19th
by Zacks Equity Research
HHR, CVS, PSX, and HCCI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 19, 2021.
Zacks Industry Outlook Highlights: CVS Health, Rite Aid and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Rite Aid and Amazon
Top Research Reports for Microsoft, Berkshire Hathaway & Oracle
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Berkshire Hathaway Inc. (BRK.B), and Oracle Corporation (ORCL).
2 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from the growing demand for digital healthcare support. Industry players like CVS and RAD are likely to gain the most. However, reimbursement challenges are hurting the overall industry health.
CVS Health (CVS) Q3 Earnings Top Estimates, 2021 EPS View Up
by Zacks Equity Research
Strength in all three operating segments drove CVS Health's (CVS) revenues in the third quarter of 2021.
CVS Health (CVS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 10.06% and 5.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Sprouts Farmers (SFM) to Post Q3 Earnings: Key Aspects to Note
by Zacks Equity Research
Sprouts Farmers (SFM) third-quarter performance is likely to have been affected by moderation of at-home dining trends.
Is a Surprise Coming for CVS Health (CVS) This Earnings Season?
by Zacks Equity Research
CVS Health (CVS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
CVS Health (CVS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
CVS Health's (CVS) consumer-centric digital approach to administering vaccines across the nation is expected to have strongly contributed to its Q3 performance.
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Retail and Wholesale
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $88.32, marking a +0.73% move from the previous day.